Investigator
Nicolaos Joseph Christodoulides
ORALIVA, INC. · funded by NCI, NIDCR
- Companies
- 2
- Grants
- 3
- Non-dilutive funding
- $2.3M
- First award
- Apr 15, 2025
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- ORALIVA, INC.49momentum
OncologyGrant-only
- ORALIVA, INC.22momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R41
Point of care diagnostic to improve access to gynecological screening in low-resource settings
$400kSep 1, 2025NCIORALIVA, INC.NIH RePORTER · 11186207 (opens the source filing in a new tab)
- R44
AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care
$1.2MApr 15, 2025NIDCRORALIVA, INC.NIH RePORTER · 10921587 (opens the source filing in a new tab)
- R44
AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care
$697kApr 15, 2025NIDCRORALIVA, INC.NIH RePORTER · 11321546 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources